Marie Bosslett, Assistant Editor

Nayan Patel, PharmD, reveals how innovative glutathione delivery transforms skin care, combats oxidative stress, and empowers skin health for lasting results.

Find out what skin care products and aesthetic innovations clinicians are recommending to patients for the month of September.

New guidelines redefine short-term corticosteroid use in patients with AD, urging safer treatment transitions to advanced therapies for better outcomes.

Experts discuss innovative topical therapies for pediatric AD, emphasizing individualized treatment and the importance of managing itch and sleep quality.

Discover how Auro GSH by Nayan Patel, PharmD, revolutionizes glutathione delivery in skin care, targeting oxidative stress for healthier skin.

Thazin Aung, PhD, discusses AI's role in standardizing immune cell evaluation in melanoma, enhancing diagnostic consistency and clinical decision-making.

Krystal Biotech enhances B-VEC's label, empowering DEB patients with at-home treatment options and improving quality of life through innovative gene therapy.

Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series!

In case you missed it, this week we had news about the long-term safety of Amgen’s rocatinlimab for AD, the shared genetic backgrounds of cardiovascular diseases and psoriasis, the availability of LEO Pharma's delgocitinib cream, and more.

Explore the complex genetic links between psoriasis and cardiovascular diseases, highlighting the IL-23 and IL-17 pathways' role in health risks.

Darker skin tones face higher risks of photosensitivity and thermal burns during dual-wavelength laser therapy, highlighting the need for tailored treatment approaches.

Discover how medium-to-deep chemical peels effectively treat refractory melasma, enhancing skin tone and quality with tailored approaches.

Explore innovative treatments for seborrheic dermatitis, including roflumilast foam, and learn about effective patient-centered care strategies.

Dermalogica's PRO Pen Microneedling System gains FDA clearance, revolutionizing non-invasive skin treatments with advanced technology and customizable options.

Amlitelimab shows promising phase 3 results in treating atopic dermatitis, achieving significant skin clearance and potential for infrequent dosing.

This review of the latest dermatologic studies highlights new research on novel image fusion for tongue SCC, persistent nodules following HA fillers, rice bran extract for wound healing, and more.

Isotretinoin significantly reduces inflammatory cytokines IL-8, IL-36, and TWEAK in acne patients, promoting long-term acne remission and healing.

New insights reveal psoriasis patients' challenges with family planning and pregnancy, highlighting the need for better information and support from healthcare providers.

Phase 3 topline results reveal rocatinlimab's promising safety and efficacy for moderate to severe AD, targeting the OX40 receptor.

Medicus Pharma has initiated a phase 2 trial in the UAE for a non-invasive BCC treatment, aiming to revolutionize skin cancer care.

New findings reveal the effectiveness of corticosteroids and Janus kinase (JAK) inhibitors post noncultured epidermal suspension (NCES) transplantation for vitiligo, highlighting varied repigmentation responses.

Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series!

In case you missed it, this week we had news about Arcutis' sNDA for roflumilast in pediatric plaque psoriasis patients, Replimune's Type A meeting with the FDA on RP1, insights on deuruxolitinib for hair growth in alopecia, and more.

Explore how model-informed drug development shapes ligelizumab's journey in treating chronic spontaneous urticaria, despite its eventual discontinuation.

Thermage FLX achieves 5 million treatments, showcasing its trusted non-surgical skin tightening technology for smoother, youthful skin.

Sofia Wenzler, PhD, highlights the vital role dermatologists play in treating body-focused repetitive behaviors like skin picking and hair pulling.

EAACI's report highlights current practices and challenges in diagnosing and managing chronic urticaria in pediatric patients, emphasizing the need for improved education and resources.

COVID-19 significantly delayed melanoma diagnoses and treatments, leading to increased disease severity and advanced cases, highlighting urgent health care needs.

Arcutis Biotherapeutics seeks FDA approval for Zoryve cream to treat plaque psoriasis in children as young as 2, addressing a critical treatment gap.

Allergan Aesthetics has launched an initiative to educate on HA fillers, emphasizing safety and natural results, backed by expert insights and patient satisfaction data.